All-trans retinoic acid (ATRA) has anti-tumor and anti-angiogenesis effects on human ESCC by inhibiting vascular endothelial growth factor (VEGF)-mediated signal transduction [10]. This evidence concerns the gene VEGFA and neoplasm.